
Episode #5
S3E5 - Australian Chlamydia Guidelines for Exams
Welcome to Season 3 of AMC Clinical Deep Dive! As Australia’s most reported communicable disease, chlamydia is frequently asymptomatic (85%–90%), making screening protocols a favourite examiner target. This episode breaks down the latest guidelines: prioritising doxycycline (100mg BD for 7 days) over azithromycin, selecting highly sensitive self-collected vaginal swabs over urine, and managing pregnant patients (who require azithromycin and a mandatory 4-week test of cure). We dive into tracing partners back 6 months, implementing Patient-Delivered Partner Therapy (PDPT), and scheduling the mandatory 3-month retest. Deliver a flawless, high-scoring clinical plan today! #AMCClinicalExam #Chlamydia #OSCE #Doxycycline #Patient-DeliveredPartnerTherapy(PDPT) #TestofCure #IMGAustralia #ASHMGuidelines #SexualHealthHistory #NAAT Pro Tip: In your OSCE, do not default to Azithromycin for everyone! Doxycycline (100 mg BD for 7 days) is now the first-line recommendation for uncomplicated chlamydia. If your patient is pregnant , remember two non-negotiable rules: first, treat with Azithromycin 1g stat; second, a Test of Cure (TOC) is mandatory and must be done by NAAT no earlier than 4 weeks after treatment is completed to avoid false-positive DNA results. Additionally, discussing Patient-Delivered Partner Therapy (PDPT) for eligible heterosexual partners demonstrates the state-of-the-art public health integration examiners love to reward! Episodes in Season 1 ( 150 clinical scenarios ) have been indexed by topic , patient group , discipline , setting , and more to support targeted learning. Use the filters to locate discussions relevant to your study or clinical training.

